Abstract
Growth and metastasizing of Lewis lung carcinoma were accompanied by complex changes in tumor sensitivity to cisplatin. On day 17 of growth, tumor sensitivity was much lower than immediately after transplantation. Further growth of Lewis lung carcinoma was accompanied by a progressive increase in its sensitivity to cytostatic treatment. The study of migration activity of the tumor and dynamics of metastasizing showed that metastatically active carcinoma cells dominated on day 17 of tumor growth, but then the number of these cells progressively decreased to the 29th day of tumor growth. Growth-related changes in the sensitivity of Lewis lung carcinoma were probably due to complex variations in the number of metastatically active tumor cells with high resistance to cisplatin.
Similar content being viewed by others
REFERENCES
C. Bell P. Frost R. S. Kerbel (1991) Cancer Genet. Cytogenet. 54 IssueID2 153–161 Occurrence Handle1884347 Occurrence Handle1:STN:280:DyaK3Mzls1Crtw%3D%3D
M. L. Boer ParticleDen R. Pieters A. J. Veerman (1998) Leukemia 12 1657–1670
R. S. Kerbel H. Kobayashi C. H. Graham (1994) J. Cell. Biochem. 56 37–47 Occurrence Handle7806590 Occurrence Handle1:CAS:528:DyaK2cXlvFCkt74%3D
A. V. Kolobov A. A. Polezhaev G. I. Solyanik (2000) J. Theor. Med. 3 63–77
J. T. Leith P. Heyman J. K. DeWyngaert et al. (1983) Cancer Res. 43 3240–3246 Occurrence Handle6850634 Occurrence Handle1:STN:280:DyaL3s3gs1KjtQ%3D%3D
Y. Liang S. McDonnell M. Clynes (2002) Cur. Cancer Drug Target 2 IssueID3 257–277 Occurrence Handle1:CAS:528:DC%2BD38XmtF2rsbg%3D
T. Mosmann (1983) ArticleTitleMethods J. Immunol. 65 IssueID1–2 55–63 Occurrence Handle10.1016/0022-1759(83)90303-4 Occurrence Handle1:STN:280:DyaL2c%2FovFSmtw%3D%3D
G. L. Nicolson A. S. Moustafa (1998) In Vivo 12 IssueID6 579–588 Occurrence Handle9891220 Occurrence Handle1:STN:280:DyaK1M7gvVeluw%3D%3D
J. W. Rak R. S. Kerbel (1993) In Vitro Cell Dev. Biol. Anim. 29A IssueID9 742–748 Occurrence Handle8407718 Occurrence Handle1:STN:280:DyaK2c%2Fht1ertw%3D%3D
G. I. Solyanik (1998) The Physics of the Alive 6 IssueID2 59–64
W. F. Symmans J. Liu D. V. Knowles G. Inghirami (1995) Hum. Pathol. 26 IssueID2 210–216 Occurrence Handle7860051 Occurrence Handle1:STN:280:DyaK2M7mtl2hsw%3D%3D
D. Theodorescu I. Cornil C. Sheehan et al. (1991) Int. J. Cancer 47 118–123 Occurrence Handle1985866 Occurrence Handle1:STN:280:DyaK3M%2Fpt1Kqug%3D%3D
Yu. R. Yakshibaeva O. N. Pyaskovskaya G. I. Solyanik V. F. Chekhun (2002) Exp. Oncol. 24 155–156
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 138, No. 9, pp. 333–336, September, 2004
Rights and permissions
About this article
Cite this article
Solyanik, G.I., Garmanchuk, L.V., Pyaskovskaya, O.N. et al. Sensitivity of Lewis lung carcinoma to cisplatin undergoes considerable variations during growth and metastasizing. Bull Exp Biol Med 138, 295–297 (2004). https://doi.org/10.1007/s10517-005-0024-9
Received:
Issue Date:
DOI: https://doi.org/10.1007/s10517-005-0024-9